Italian guidelines for staging and follow-up of stage I-II cutaneous melanoma patients

Pietro Quaglino(Department of Medical Sciences), Maria Grazia Bernengo(University of Turin), Nicola Pimpinelli(University of Florence), Ugo Bottoni(Magna Graecia University), Lorenzo Borgognoni(Tumour Institute of Tuscany), Stefano Calvieri(Sapienza University of Rome), Caterina Catricalà(San Gallicano Hospital), Silvia Moretti(University of Insubria), Paolo Carli(University of Florence), Ausilia Maria Manganoni(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Giovanni Pellacani(Sapienza University of Rome), Stefania Seidenari(University of Modena and Reggio Emilia), Laura Eibenschutz(San Gallicano Hospital)
Florence Research (University of Florence)
January 1, 2007
Cited by 15

Related Papers

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
|Blood|2007|1.4k
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Cigarette Smoking, Body Mass Index, and Stressful Life Events as Risk Factors for Psoriasis: Results from an Italian Case–Control Study
|Journal of Investigative Dermatology|2005|644
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Defining early mycosis fungoides
|Journal of the American Academy of Dermatology|2005|543